Anest. intenziv. Med. 2023;34(4):147-151 | DOI: 10.36290/aim.2023.052

Incidence of amniotic fluid embolism in the Czech Republic - a questionnaire studyOriginal Article

Pešková K.1, 3, Štourač P.2-4, Seidlová D.1, 3
1 II. anesteziologicko resuscitační oddělení, Fakultní nemocnice Brno
2 Klinika dětské anesteziologie a resuscitace, Fakultní nemocnice Brno
3 Lékařská fakulta Masarykovy univerzity, Brno
4 Ústav simulační medicíny, Lékařská fakulta Masarykovy univerzity, Brno

Aims of the study: to determine the incidence of amniotic fluid embolism in the Czech Republic and the availability of immediate transthoracic echocardiography (TTE) examination in the departments performing obstetric anesthesia and intensive care. Study type: multicentre questionnaire study.

Methods: All 87 anesthetics departments performing obstetric anesthesia in the Czech Republic were invited to complete an online questionnaire on the period 2018-2020. The data collection took place from September to December 2021.

Results: 42 departments (collectively responsible for 52% of all births in the Czech Republic) responded to the invitation. In total, 8 cases of amniotic fluid embolism were recorded at these departments over the study period; of these, one patient died and seven survived without permanent sequelae. No immunological diagnostics was performed. Echocardiography was used for diagnosis in 25 % of cases. 23 % of the responding departments do have internal guidelines for the management of suspected amniotic fluid embolism ready and 50 % can provide emergency bedside TTE examination.

Conclusions: The incidence of amniotic fluid embolism in the Czech Republic in 2018-2020 ranged between 1.7 and 6.7/ 100 000 labours in the respective years. In all, eight cases were recorded, one of which was fatal.

Keywords: amniotic fluid embolism, incidence, echocardiography.

Received: July 20, 2023; Revised: October 29, 2023; Accepted: November 3, 2023; Prepublished online: November 30, 2023; Published: December 15, 2023  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Pešková K, Štourač P, Seidlová D. Incidence of amniotic fluid embolism in the Czech Republic - a questionnaire study. Anest. intenziv. Med. 2023;34(4):147-151. doi: 10.36290/aim.2023.052.
Download citation

References

  1. Society for Maternal­‑Fetal Medicine (SMFM). Electronic address: pubs@smfm.org; Pacheco LD, Saade G, Hankins GD, Clark SL. Amniotic fluid embolism: diagnosis and management. Am J Obstet Gynecol. 2016 Aug;215(2):B16-24. doi: 10.1016/j.ajog.2016. 03. 012. Epub 2016 Mar 14. PMID: 26987420. Go to original source...
  2. Clark SL, Romero R, Dildy GA, Callaghan WM, Smiley RM, Bracey AW, et al. Proposed diagnostic criteria for the case definition of amniotic fluid embolism in research studies. Am J Obstet Gynecol. 2016 Oct;215(4):408-12. doi: 10.1016/j.ajog.2016. 06. 037. Epub 2016 Jun 29. PMID: 27372270; PMCID: PMC5072279. Go to original source...
  3. Acker LC, Jones RC, Rasouli MR, Bronshteyn YS. Focused Cardiac Ultrasound during Amniotic Fluid Embolism. Anesthesiology. 2019 Jun;130(6):1032-1033. doi: 10.1097/ALN.0000000000002596. PMID: 30762592. Go to original source... Go to PubMed...
  4. Fitzpatrick KE, van den Akker T, Bloemenkamp KWM, Deneux­‑Tharaux C, Kristufkova A, Li Z, et al. Risk factors, management, and outcomes of amniotic fluid embolism: A multicountry, population­‑based cohort and nested case­‑control study. PLoS Med. 2019 Nov 12;16(11):e1002962. doi: 10.1371/journal.pmed.1002962. PMID: 31714909; PMCID: PMC6850527. Go to original source... Go to PubMed...
  5. Skolnik S, Ioscovich A, Eidelman LA, Davis A, Shmueli A, Aviram A, et al. Anesthetic management of amniotic fluid embolism -- a multi­‑center, retrospective, cohort study. J Matern Fetal Neonatal Med. 2019 Apr;32(8):1262-1266. doi: 10.1080/14767058.2017.1404024. Epub 2017 Nov 22. Erratum in: J Matern Fetal Neonatal Med. 2019 Sep;32(17):2953. PMID: 29166810. Go to original source... Go to PubMed...
  6. Korbeľ M, Krištúfková A, Daniš J, Némethová B, Kaščák P, Nižňanská Z. Maternal morbidity and mortality in Slovak Republic in the years 2007-2015. Ceska Gynekol. 2019 Winter;84(2):129-139. English. PMID: 31238683.
  7. Korbeľ M, Krištúfková A, Dugátová M, Daniš J, Némethová B, Kaščák P, et al. Analýza materskej morbidity a mortality v Slovenskej republike v rokoch 2007-2012 [Analysis of maternal morbidity and mortality in Slovak Republic in the years 2007-2012]. Ceska Gynekol. 2017 Winter;82(1):6-15. Czech. PMID: 28252305.
  8. Korbeľ M, Krištúfková A, Daniš J, Adamec A, Vargová M, Kaščák P, et al. Severe maternal morbidity in the Slovak Republic in the years 2012-2018. Ceska Gynekol. 2022;87(2):93-99. English. doi: 10.48095/cccg202293. PMID: 35667859. Go to original source... Go to PubMed...
  9. Phillips AN, Kirkland LL, Wagner WE, Melamed R, Tierney DM. Utilization of point­‑of­‑care ultrasound and rotational thromboelastometry (ROTEM) in the diagnosis and management of amniotic fluid embolism presenting as post­‑partum hemorrhage and cardiac arrest. Case Rep. Perinat. Med. 2022 Jan;11(1):20220009. doi: 10.1515/crpm-2022-0009. Go to original source... Go to PubMed...
  10. Patient Safety and Quality Committee, Society for Maternal­‑Fetal Medicine. Electronic address: smfm@smfm.org; Combs CA, Montgomery DM, Toner LE, Dildy GA. Society for Maternal­‑Fetal Medicine Special Statement: Checklist for initial management of amniotic fluid embolism. Am J Obstet Gynecol. 2021 Apr;224(4):B29-B32. doi: 10.1016/j.ajog.2021. 01. 001. Epub 2021 Jan 6. PMID: 33417901. Go to original source...
  11. Krištúfková A, Borovský M, Daniš J, Adamec A, Vargová M, Korbeľ M. The International Network of Obstetric Survey System. Ceska Gynekol. 2020 Winter;85(2):139-143. English. PMID: 32527109.
  12. Oda T, Tamura N, Kanayama N. Japanese viewpoint on amniotic fluid embolism. Am J Obstet Gynecol. 2017 Jul;217(1):91. doi: 10.1016/j.ajog.2017. 02. 034. Epub 2017 Feb 24. PMID: 28238668. Go to original source...
  13. Ponzio­‑Klijanienko A, Vincent­‑Rohfritsch A, Girault A, Le Ray C, Goffinet F, Bonnet MP. Evaluation of the 4 diagnosis criteria proposed by the SMFM and the AFE foundation for amniotic fluid embolism in a monocentric population. J Gynecol Obstet Hum Reprod. 2020 Nov;49(9):101821. doi: 10.1016/j.jogoh.2020.101821. Epub 2020 May 28. PMID: 32474192. Go to original source... Go to PubMed...
  14. Erez O, Othman M, Rabinovich A, Leron E, Gotsch F, Thachil J. DIC in Pregnancy - Pathophysiology, Clinical Characteristics, Diagnostic Scores, and Treatments. J Blood Med. 2022 Jan 6;13:21-44. doi: 10.2147/JBM.S273047. PMID: 35023983; PMCID: PMC8747805. Go to original source... Go to PubMed...
  15. Matsunaga S, Masuko H, Takai Y, Kanayama N, Seki H. Fibrinogen may aid in the early differentiation between amniotic fluid embolism and postpartum haemorrhage: a retrospective chart review. Sci Rep. 2021 Apr 16;11(1):8379. doi: 10.1038/s41598-021-87685-y. PMID: 33863968; PMCID: PMC8052446. Go to original source... Go to PubMed...
  16. Aissi James S, Klein T, Lebreton G, Nizard J, Chommeloux J, Bréchot N, et al. Amniotic fluid embolism rescued by venoarterial extracorporeal membrane oxygenation. Crit Care. 2022 Apr 7;26(1):96. doi: 10.1186/s13054-022-03969-3. PMID: 35392980; PMCID: PMC8988404. Go to original source... Go to PubMed...




Anesteziologie a intenzivní medicína

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.